SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950162-08-000089
Filing Date
2008-02-13
Accepted
2008-02-13 14:57:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCICLONE PHARMACEUTICALS/CLAUDIO CAVAZZA SCHEDULE 13G/A NO. 5 scicloneclaudo13gano5_021308.htm SC 13G/A 57160
  Complete submission text file 0000950162-08-000089.txt   58831
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43408 | Film No.: 08603935
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 ROME ITALY L6 00000
Business Address
CAVAZZA CLAUDIO (Filed by) CIK: 0001164803 (see all company filings)

Type: SC 13G/A